Lake Forest Academy

IntroductionAlzheimer's disease is a worldwide progressive neurodegenerative disease.In the past two decades, acetylcholinesterase (AChE) inhibitors have been the most popular medication in mitigating Alzheimer's disease symptoms.However, all common AChE inhibitors have side effects, and traditional inhibitor discovery is a very expensive and timely process.Replacing the traditional workflow with computational experiments, this research selected novel candidate AChE inhibitors for future drug development.Methods 18 compounds were retrieved after virtually screening for pharmacophore structures affinitive to AChE.After compounds' interaction simulations with the AChE, their inhibition efficiencies were ranked based on Gibb's free energy of.Then the research further evaluated the compounds' oral bioavailability and ability to across the blood brain barrier by comparing their properties with the Lipinski's rule of 5. ResultsOverall, 17 out of 18 compounds passed the Lipinski's rule of 5, qualifying good absorption and permeation.While compound ZINC04713297 featured the best inhibition efficiency (-9.37kcal/mol), both ZINC92926669 and ZINC08756522 required the second lowest reaction energy (-9.20kcal/mol).ZINC92926669 stood out among the two in the absorption assessment for its stability and portability in the blood stream. ConclusionThis research discovered 17 novel AChE inhibitors through the workflow combining virtual screening, interaction simulation and absorption assessment.It highlighted compound ZINC04713297 and ZIN92926669, which served as a starting point for development of novel acetylcholinesterase inhibitors for Alzheimer's disease.

Articles on biology and medicine are published in the journal. Journal is published in&nbsp;<strong>English&nbsp;</strong>in electronic form. Example of output data of an article &ndash;&nbsp;<em>Mark, Smith. Development of cancer treatment in Europe // The European Journal of Biomedical and Life Sciences, №3, 2022,

This paper analyzed four classic Disney movies that embody feminism. People around the world all like to watch Disney movies. For example, Mulan and Cinderella. However, we did not discover those great movies' feminist ideas and gender concepts. In this paper, we aim to find the plots and core ideas that symbolize gender ideas and try to discover the concepts of feminism in these movies. We distributed our group members to different movies, worked on plot-analyzing and essential concepts, and then reflected on our paper. Furthermore, we wish to explore different details when comparing the same story filmed in different periods. Take Mulan 1998 and Mulan 2020, for instance; even though the professional filming team in Disney wanted to create a real "Mulan" in the movie, the difference in period would bring different comprehensions to the team.

Clinical depression can be described as a common medical disorder that negatively affects how an individual feels, thinks, and acts. Today, the chances of a person suffering from depression are much more common worldwide, and it is critical to understand depression and most importantly how to treat the disease. While it currently remains unclear exactly how depression works in the human body, research shows that a protein called P11 might play a vital role in the molecular and cellular mechanisms underlying depression in the body. According to research, as the level of P11 protein decreases, it increases an individual’s risk of undergoing depression. The main problem is that the existing treatment, which includes medication and psychotherapy, is not as effective as it could be for treating such a disease. Genetic therapy treatment would be an attractive alternative treatment for depression treatment since regulating the levels and mechanisms involving protein P11 would hopefully alleviate one’s symptoms of depression in the body. This paper intends to highlight the benefits of using gene therapy to treat depression and elaborate on why the treatment may be useful.

Background: Pediatric sepsis is a significant public health issue. This condition is exacerbated by rising serum creatinine and inflammatory cytokines that lead to deleterious effects upon the body. The current standard of care involves the use of continuous kidney replacement therapy to remove harmful cytokines until the body returns to homeostasis. In order to promote faster clearance and reduced stay in the ICU, high-volume hemofiltration (HVHF) has shown promise. However, there is a paucity of studies to fully elucidate its benefits. Methods: A literature search was done using PubMed/ MEDLINE and Embase. The literature was reviewed by two independent reviewers, who independently assessed the quality of randomized controlled trials by using the Cochrane risk of bias tool for RCTs and Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized controlled trials. Data were combined from studies with a similar design. Results: The primary endpoint of all-cause mortality was found to be reduced by 40% across all of the pooled studies. For secondary endpoints, significant reductions of serum creatinine were found. Additionally, duration of ICU stays and treatment course was found to be significantly shorter in HVHF patients than the current standard of care. The rate of adverse effects was analyzed, and there was no difference in the proportion of patients developing hypokalemia, hyperkalemia, hypernatremia, or hyponatremia. The proportion of patients developing hyperglycemia was higher in patients undergoing HVHF, whereas the proportions of patients developing bleeding were significantly less in patients undergoing HVHF. One study reported a total number of adverse events between the two groups which were significantly lesser in patients undergoing HVHF. Conclusion: HVHF shows promise as a modality to treat pediatric patients with sepsis. In order to confirm the benefits of this modality, future studies need significantly more patients for analysis.

With the development of society, people's living standards are constantly improving. The price model of farm products is strongly connected to fluctuations in the cost of the food & processing industry as a whole. This paper selects stock prices of COFCO, China Oil and Foodstuffs Corporation and CPI

To assess the efficacy and safety of lansoprazole in the treatment of adolescents with symptomatic, endoscopically proven, non-erosive gastroesophageal reflux disease and erosive esophagitis. Adolescents between 12 and 17 years of age with esophagitis were enrolled in this open-label trial and treated with lansoprazole 15 mg (non-erosive) or 30 mg (erosive) once daily for 8 weeks. If unhealed at week 8, those with erosive esophagitis were treated with an additional 4 weeks of lansoprazole 30 mg once daily. Lansoprazole produced a significant reduction from baseline in the median percentage of days with reflux symptoms (91 to 43% in the 64 adolescents with non-erosive disease and 85 to 16% in the 23 adolescents with erosive esophagitis, P < or = 0.001 for each comparison). At week 8, mucosal healing had occurred in 95% (21 of 22) of those with erosive esophagitis. Treatment-related adverse events were reported by 19% of patients with non-erosive and 4% of patients with erosive esophagitis. Headache (7%), abdominal pain (5%), nausea (3%) and dizziness (3%) were the most frequently reported adverse events. One patient discontinued treatment early because of dizziness and vomiting. An elevation in mean serum gastrin from baseline (59 pg/mL at pretreatment to 80 pg/mL at final visit) was observed. Lansoprazole 15 mg or 30 mg once daily reduced symptoms of gastroesophageal reflux in adolescents with non-erosive gastroesophageal reflux disease and erosive esophagitis, respectively. Lansoprazole 30 mg once daily for 8 weeks was effective in healing erosive esophagitis. Both treatment regimens were considered safe.

(1983). Odor Character Profiling. Journal of the Air Pollution Control Association: Vol. 33, No. 8, pp. 775-778.